SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001123292-18-000974
Filing Date
2018-09-28
Accepted
2018-09-28 16:33:02
Documents
4
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 novartis13g_09282018.htm SC 13G 65550
2 image1.jpg GRAPHIC 127691
3 image2.jpg GRAPHIC 81260
4 image00003.jpg GRAPHIC 132895
  Complete submission text file 0001123292-18-000974.txt   538251
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82437 | Film No.: 181094561
SIC: 2836 Biological Products, (No Diagnostic Substances)